The proposal from the Food and Drug Administration and mandated by Congress is intended to reassure consumers about the safety of makeup, baby powder and other personal care products. It follows years ...

The IV version of the drug has a list price of $7,635 per infusion for two weeks for the lower dose and $15,269 per infusion for four weeks for the higher 480-milligram dose. The approval was ...

BeiGene (BGNE), a global oncology company that intends to change its name to BeOne Medicines, announced the U.S. FDA has approved Tevimbra in combination with platinum and fluoropyrimidine-based ...

An icon in the shape of a lightning bolt ... That doesn't mean that drug testing on Wall Street is dead, however. Indeed, many large banks have strict rules against using substances at work ...

The Food and Drug Administration has placed its highest warning on thousands of eggs distributed to Costco locations in five states last month, saying there’s a “reasonable possibility” that ...

Isaacman, who founded Shift4 Payments and commanded SpaceX’s Inspiration4 mission and Polaris Dawn, brings a unique mix of business success and space exploration experience. His nomination ...

The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...

But then in an updated notice issued on Friday, the FDA reclassified to recall to a Class I, which the agency calls a "reasonable probability that the use of, or exposure to, a violative product ...

When Hendeles and his colleagues first petitioned the FDA on phenylephrine, they suggested a higher dose might be effective. But subsequent studies showed that even doses 400% higher than those ...